INS and metabolic dysfunction-associated steatotic liver disease: There is no evidence of arginine metabolism dysregulation in MASLD, but the decreased concentrations in these children could be a sign of glucose and insulin alterations that are known to be correlated with hepatic steatosis and obesity [35].